Pharmaceuticals Financial News
29.05 / 16:31
IPO
Booking
Manufacturing
Platform
band
Updates
Pharmaceuticals
GSM Foils IPO share allotment: How to check status? A step-by-step guide
GSM Foils IPO Allotment Update: After receiving a stellar response from investors during the bidding period from May 24 to May 28, attention now turns to the allotment procedure for the GSM Foils IPO.The allotment for the GSM Foils IPO is expected to be finalised today. Investors can monitor their allotment status through the registrar, Bigshare Services Pvt.
29.05 / 11:39
markets
SUN
WhatsApp
Nestle
Updates
Pharmaceuticals
Stock market update: Sugar stocks down as market falls
EID Parry(India)Ltd.(up 8.29%), KM Sugar Mills Ltd.(up 4.46%), Simbhaoli Sugars Ltd.(up 3.18%), KCP Sugar & Industries Corporation Ltd.(up 1.75%), DCM Shriram Industries Ltd.(up 0.91%), Balrampur Chini Mills Ltd.(up 0.71%), Shree Renuka Sugars Ltd.(up 0.61%), Mawana Sugars Ltd.(up 0.61%), Dalmia Bharat Sugar and Industries Ltd.(up 0.56%) and Uttam Sugar Mills Ltd.(up 0.19%) stood among the top gainers.
29.05 / 11:39
markets
SUN
Nestle
Trade
Updates
Pharmaceuticals
Share market update: Most active stocks of the day in terms of traded value
The NSE Nifty index ended the session 183.46 points down at 22704.7, while BSE Sensex fell 667.55 points to 74502.9.
29.05 / 10:49
SUN
Nestle
AGRO
Pharmaceuticals
Top Gainers and Losers today on 29 May, 2024: Hindalco Industries, Power Grid Corporation Of India, HDFC Life Insurance Company, SBI Life Insurance Company among most active stocks; Check full list here
Sensex:Top Gainers: Power Grid Corporation Of India (up 1.52%), Sun Pharmaceutical Industries (up 0.92%), Nestle India (up 0.71%), ITC (up 0.44%), Bharti Airtel (up 0.26%)Top Losers: Tech Mahindra (down 2.35%), ICICI Bank (down 2.19%), Axis Bank (down 1.92%), Bajaj Finserv (down 1.89%), HDFC Bank (down 1.48%)Nifty:Top Gainers: Hindalco Industries (up 3.52%), Power Grid Corporation Of India (up 1.57%), Divis Laboratories (up 1.27%), Nestle India (up 1.00%), Sun Pharmaceutical Industries (up 0.96%)Top Losers: HDFC Life Insurance Company (down 2.87%), SBI Life Insurance Company (down 2.62%), ICICI Bank (down 2.21%), Tata Consumer (down 2.21%), Tech Mahindra (down 2.18%)Nifty MidCap 50:Top Gainers: Suzlon Energy, Jubilant Foodworks, Au Small Finance Bank, L&T Finance Holdings, Vodafone IdeaTop Losers: HDFC Asset Management Company, Ashok Leyland, Tube Investments Of India, Hindustan Petroleum Corporation, AstralNifty Small Cap 100:Top Gainers: Cochin Shipyard, Baheti Recycling Industries, Housing & Urban Development Corporation, Great Eastern Shipping Company, Finolex CablesTop Losers: PNB Housing Finance, Ujjivan Small Finance Bank, Arham Technologies, Narayana Hrudayalaya, ITIBSE:Top Gainers: Sumitomo Chemical India (up 8.79%), Grindwell Norton (up 8.70%), Eid Parry India (up 8.18%), BHARAT DYNAMICS (up 5.99%), Cochin Shipyard (up 5.92%)Top Losers: IFB Industries (down 9.94%), Hatsun Agro Product (down 8.39%), EIGHTY JEWELL-MT (down 7.58%), PNB Housing Finance (down 6.69%), ICICI Prudential Life Insurance Company (down 4.41%)NSE:Top Gainers: Sumitomo Chemical India (up 9.03%), Grindwell Norton (up 8.33%), Eid Parry India (up 8.28%), BHARAT DYNAMICS (up 6.01%), Finolex Industries (up 5.75%)Top Losers: Master Components
29.05 / 03:51
markets
IPO
Manufacturing
Sustainability
trends
Trade
Pharmaceuticals
GSM Foils IPO allotment to be finalised today. Here's how you can check status
GSM Foils is likely to finalise the share allotment process today. Investors can check the status of GSM Foils IPO allotment by logging in to the official website of the registrar, which is Bigshare Services in this case. Follow the step-by-step process mentioned below to check the status of allotment.
29.05 / 00:19
markets
UPS
Target
wellness
Equality
Pharmaceuticals
Emkay sees Nifty at 24,500 by year-end
Emkay Investment Managers expects the Nifty to reach 24,500 levels by 2024-end and has set a target of 26,500 on the index by end of 2025. The Nifty closed at 22,888 on Tuesday. Manish Sonthalia, chief investment officer at Emkay Investment Managers, suggested investors to follow a multi-cap approach with equal proposition in large-caps and mid-caps to take advantage of a broad-based growth in Indian equity markets.
28.05 / 11:09
markets
UPS
Trade
Updates
International
Pharmaceuticals
Stock market update: Nifty Pharma index advances 0.54%
Shares of Glenmark Pharmaceuticals Ltd.(up 3.65 per cent), Divi's Laboratories Ltd.(up 3.22 per cent), Aurobindo Pharma Ltd.(up 2.07 per cent), Ipca Laboratories Ltd.(up 1.79 per cent) and Dr. Reddy's Laboratories Ltd.(up 1.58 per cent) ended the day as top gainers in the pack.
27.05 / 19:01
Manufacturing
Action
Research
Experts
reports
recommendations
Pharmaceuticals
Panel to examine if nutraceuticals can be produced within drug unit
committee will examine if manufacturing of nutraceuticals should be allowed within drug manufacturing facilities. India's drug regulator had said earlier that action will be taken against those flouting norms by manufacturing supplements and drugs in the same facility. However, following objections raised by various pharma lobbies, the drug regulator has formed a committee that will give its recommendations within three weeks on the issue. The committee comprises senior officials from the regulatory authority, experts from the National Institute of Pharmaceutical Education and Research (NIPER) and an industry expert.
27.05 / 17:15
markets
Provident
ETF
CEO
Trade
Amgen
Pharmaceuticals
This new weight loss drug ETF bets big on two of the industry's leading players
A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.
27.05 / 11:41
markets
WhatsApp
Trade
Updates
Pharmaceuticals
Stock market update: Nifty Pharma index falls 0.04%
Shares of Glenmark Pharmaceuticals Ltd.(up 8.06 per cent), J B Chemicals & Pharmaceuticals Ltd.(up 6.87 per cent), Divi's Laboratories Ltd.(up 3.23 per cent), Mankind Pharma Ltd.(up 2.5 per cent) and Granules India Ltd.(up 2.33 per cent) ended the day as top gainers in the pack.
27.05 / 06:29
markets
MET
Election
Healthcare
show
Pharmaceuticals
General Elections 2024: How different poll outcome scenarios will impact equity, forex and bond markets
Outright BJP victory: Nomura expects positive market reaction particularly if NDA gets close to 400 seats. Domestic sectors particularly financials, consumer discretionary, industrials/infrastructure and PSUs will outperform.
27.05 / 06:29
UPS
Pharmaceuticals
Torrent Pharmaceuticals, Bosch & others hit 52 week high today ; Do you own any?
Bank Nifty was up by 347.3(0.71%) at 27 May 2024 10:44:56 IST.Other stocks such as Best Agrolife, Compuage Infocom, GSS Infotech, RAJRATAN GLO, Future Retail hit their fresh 52 wk lows today.
27.05 / 04:23
markets
Healthcare
Trade
Experts
reports
Pharmaceuticals
Unstoppable bull run! Sensex, Nifty hit fresh lifetime highs on strong global market cues
Asian counterparts, Indian blue-chip indices hit fresh record highs on Monday, driven by financial and metal stocks. The BSE Sensex hit new lifetime high of 75,679 before trading 206 points or 0.27% higher, at 75,615. Meanwhile, the Nifty50 scaled new peak of 23,043 before trading 58 points or 0.25% higher at 23,015 as of 9:19 AM.
27.05 / 01:01
UPS
SUN
Trade
reports
Pharmaceuticals
Stocks in news: NTPC, Cochin Shipyard, Hindustan Copper, Karnataka Bank, Narayana Hrudayalaya
financials and metal stocks. In today's trading session, shares of NTPC, Cochin Shipyard, Hindustan Copper, Karnataka Bank, and Narayana Hrudayalaya among others will be in focus due to various news developments and quarterly earnings. NTPC
25.05 / 14:03
Action
security
Food
Trade
Pharmaceuticals
Infosys, Havells, among others to trade ex-dividend, Ajanta Pharma to declare buyback next week; Full list here
Dividend Stocks: Shares of several companies including Havells India, Infosys, CMS Info Systems Ltd, among several others will trade ex-dividend in the coming week starting from Monday, May 27. Along with these, some other stocks will also trade ex-split while Ajanta Pharma will declare a buyback.
25.05 / 07:41
markets
cover
recommendations
Updates
Pharmaceuticals
Torrent Pharmaceuticals Q4 Results Live : profit rise by 51.57% YOY
₹13.27 for Q4 which increased by 51.29% Y-o-Y.Torrent Pharmaceuticals has delivered -0.26% return in the last 1 week, 27.83% return in the last 6 months, and 16.8% YTD return.Currently, Torrent Pharmaceuticals has a market cap of ₹91139.98 Cr and 52wk high/low of ₹2782.85 & ₹1683.1 respectively.As of 25 May, 2024, out of 26 analysts covering the company, 2 analysts have given Sell rating, 4 analysts have given Hold rating, 12 analysts have given Buy rating, and 8 analysts have given Strong Buy rating.The consensus recommendation as of 25 May, 2024, was to Buy.FAQsQuestion : What is the Q4 profit/Loss as per company?Ans : ₹449CrQuestion : What is Q4 revenue?Ans : ₹2745CrStay updated on quarterly results with our results calendarMilestone Alert! Livemint tops charts as the fastest growing news website in the world
24.05 / 19:03
Provident
SUN
Gap
inclusion
innovations
Pharmaceuticals
Sun Pharma to pursue M&A, licensing to expand speciality business
Sun Pharma, India's largest drug maker, will pursue licensing and acquisitions to expand its speciality business, the company's senior executive said. «M&A — we have always tried to be very judicious; looked at ways by which we can use licensing or acquisitions as a way to fill the gaps in our portfolio and achieve our strategic goal,» said Abhay Gandhi, CEO-North America Business at Sun Pharma. «Of course, having a cash chest of close to $2.4 billion inclusive of Taro enables us to pursue mid- to large-size transactions as well,» Gandhi said.
24.05 / 18:33
Digital
Platform
wellness
innovations
information
Pharmaceuticals
Sporting
Where there is AI, there is data, in every industry
Mint Digital Innovation Summit 2024.Participating in a panel discussion on “How AI, GenAI are powering digital transformation across sectors in India", Roopa Basrur, vice-president of Global Safety Medical Writing at Parexel, a Durham, North Carolina-based biopharmaceutical services company, said workflow automation, robust decision-making, and search and retrieval of data are the areas where AI's impact has been the most in the pharmaceutical industry.Basrur emphasised the use of AI in medical writing as well, which includes using data to determine whether a drug is safe for use or if there are warning signals.“So, we actually have developed an in-house literature review tool that helps to do exactly what you were talking about, that is cutting down the amount of time spent in drug research and drug safety," said Basrur.Moving to an industry that embraced “digital" from the get go, Abhishek Ravi, chief information officer (CIO) at Mumbai-based Indian fantasy sports platform Dream Sports (Dream11), said AI technology was ever-evolving for him and not an overnight wonder.
24.05 / 16:47
community
country
innovations
medicines
International
Pharmaceuticals
mountaineering
UN countries adopt treaty to better trace origins of genetic resources under global patent system
U.N. member countries have concluded a new treaty to ensure that genetic resources used in inventions, like new medicines derived from exotic plants in the Andes mountains, are properly traced
24.05 / 15:55
markets
UPS
performer
reports
recommendations
Pharmaceuticals
Torrent Pharma board approves to raise Rs 5,000 crore
Torrent Pharma on Friday said its board has approved to raise funds up to Rs 5,000 crore for issuance of equity shares. «Recommended to the members to obtain enabling approval for issuance of equity shares including convertible bonds or debentures through Qualified Institutional Placement (QIP) and or any other modes for an amount not exceeding ₹5,000 crore in the upcoming Annual General Meeting (AGM),» the company said in a statement to stock exchanges.
24.05 / 14:03
UPS
WhatsApp
reports
recommendations
Pharmaceuticals
Torrent Pharma Q4 Results: Net profit jumps 56% YoY to Rs 449 crore
Torrent Pharmaceuticals Ltd on Friday reported a 56.45 per cent jump in consolidated net profit to Rs 449 crore in the March quarter, riding on higher revenue. The company had posted a consolidated net profit of Rs 287 crore in the same period of the previous fiscal, Torrent Pharmaceuticals said in a regulatory filing. Consolidated revenue from operations in the fourth quarter of FY24 stood at Rs 2,745 crore as against Rs 2,491 crore in the year-ago period, it added.
frequently asked questions about Pharmaceuticals
What is Pharmaceuticals and why is it gaining attention?
Pharmaceuticals is a high-demand area that interests a wide audience. On our site, we regularly publish updates related to this subject.
Where can I find the latest updates on Pharmaceuticals?
All latest articles about Pharmaceuticals can be found in the highlighted block. We publish information as it becomes available.
How can I verify the accuracy of information on Pharmaceuticals?
We use verified data to ensure that the information about Pharmaceuticals is well-supported and helpful for our readers.